Dr. Mark J. Holterman began his education journey by completing an undergrad in biology from Yale university before going on for his MD and PhD at the University of Virginia. After schooling, he went on to complete residency at the University of Virginia and fellowship at University of Washington Children’s Hospital and Medical Center. He is now a professor at the University of Illinois College of Medicine. In addition, he is also an attending surgeon at Advocate Christ Children’s Hospital.
Dr. Holterman also has memberships with many organizations and specializes in pediatric surgery.
Dr. Mark J. Holterman supports and provides assistance for charitable organizations. Such organizations include the International Pediatric Specialists Alliance for the Children of Vietnam. In order to ensure that the organization can provide surgical care, IPSAC-VN needs the support of volunteers. Volunteers provide on-site, hands-on support for the organization and are a crucial part of making the organization function. Visa and passports are needed from all volunteers (https://interview.net/dr-mark-holterman/). In addition, professional licences and CV are needed for all medical volunteers. Volunteers are trained and briefed prior to beginning volunteer hours.
Dr. Holterman is the CEO of regenerative medicine-focused Mariam Global Health (Doctors.HealthGrove). As stated before, he remains interested in cell-based therapies. In 2016, legislation was passed under President Obama and the United States Congress. This legislation aimed to assist patients who possess serious health complications to benefit from new drugs and medical devices. This legislation provides aide for the area of regenerative medicine. In addition, new funds and aide are put into medical research of all areas. The FDA is able to speed up the approval process of new drugs and procedures. This includes certain stem cell treatments, even before they enter the market. Groups such as the World Stem Cell Summit and the Alliance for Regenerative Medicine rejoiced the new legislation.